NCT02267304View on ClinicalTrials.gov

Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 30, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 30, 2016

Conditions

Healthy

Interventions

DRUG

50 mL of sodium chloride (0,9%)

DRUG

Morphine 0,05mg/kg

DRUG

Naloxone 10mg

Trial Locations (1)

75013

CIC Neurologie GHPS, Paris

All Listed Sponsors

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT02267304 - Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic) | Biotech Hunter | Biotech Hunter